Proteomics Analysis of Blood Serums from Alzheimer’s Disease Patients Using iTRAQ Labeling Technology
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proteomics Analysis of Blood Serums from Alzheimer’s Disease Patients Using iTRAQ Labeling Technology
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 56, Issue 1, Pages 361-378
Publisher
IOS Press
Online
2016-12-02
DOI
10.3233/jad-160913
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma Gelsolin is Decreased and Correlates with Rate of Decline in Alzheimer's Disease
- (2017) Andreas Güntert et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma soluble neuregulin-1 as a diagnostic biomarker for Alzheimer's disease
- (2016) Keun-A Chang et al. NEUROCHEMISTRY INTERNATIONAL
- Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
- (2016) Y. Iturria-Medina et al. Nature Communications
- Comparative Proteomic Analysis of Cultured Suspension Cells of the Halophyte Halogeton glomeratus by iTRAQ Provides Insights into Response Mechanisms to Salt Stress
- (2016) Juncheng Wang et al. Frontiers in Plant Science
- Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer’s Disease
- (2015) Istvan Horvath et al. ACS Chemical Neuroscience
- Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
- (2015) Alison L. Baird et al. Frontiers in Neurology
- Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
- (2014) Martina Sattlecker et al. Alzheimers & Dementia
- Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease
- (2014) Wenzhong Yang et al. LIFE SCIENCES
- The search for a blood-based biomarker for Alzheimer disease
- (2014) Alan Rembach Nature Reviews Neurology
- Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics
- (2014) Fei Song et al. Proteome Science
- 2015: which new directions for Alzheimer's disease?
- (2014) Xénia Latypova et al. Frontiers in Cellular Neuroscience
- Shared Mechanisms of Neurodegeneration in Alzheimer’s Disease and Parkinson’s Disease
- (2014) Anmu Xie et al. Biomed Research International
- Elevated serum copper and ceruloplasmin levels in Alzheimer's disease
- (2013) Jun-Hyun Park et al. Asia-Pacific Psychiatry
- iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance
- (2013) S Tonack et al. BRITISH JOURNAL OF CANCER
- Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
- (2013) Benjamin Lam et al. Alzheimers Research & Therapy
- Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
- (2013) Debasish Paul et al. Biomed Research International
- Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
- (2012) James D. Doecke ARCHIVES OF NEUROLOGY
- Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics
- (2012) A. Cocciolo et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pro-Inflammatory S100A8 and S100A9 Proteins: Self-Assembly into Multifunctional Native and Amyloid Complexes
- (2012) Thomas Vogl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multidimensional plasma protein separation technique for identification of potential Alzheimer’s disease plasma biomarkers: a pilot study
- (2012) Andreas Wolfram Henkel et al. JOURNAL OF NEURAL TRANSMISSION
- Methyl Jasmonate Responsive Proteins in Brassica napus Guard Cells Revealed by iTRAQ-Based Quantitative Proteomics
- (2012) Mengmeng Zhu et al. JOURNAL OF PROTEOME RESEARCH
- Association between α1-antichymotrypsin signal peptide −15A/T polymorphism and the risk of Alzheimer’s disease: a meta-analysis
- (2012) Fulin Guan et al. MOLECULAR BIOLOGY REPORTS
- Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals
- (2012) Fei Song et al. PLoS One
- Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden
- (2012) Steven John Kiddle et al. PLoS One
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
- (2011) Yu Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits
- (2011) Fabio Di Domenico et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Plasma Clusterin and the Risk of Alzheimer Disease
- (2011) Elisabeth M. C. Schrijvers JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Clusterin Levels Are Not Increased in Presymptomatic Alzheimer’s Disease
- (2011) Linda IJsselstijn et al. JOURNAL OF PROTEOME RESEARCH
- Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment
- (2011) Madhav Thambisetty et al. NEUROIMAGE
- A Serum Protein–Based Algorithm for the Detection of Alzheimer Disease
- (2010) Sid E. O’Bryant ARCHIVES OF NEUROLOGY
- Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
- (2010) Terry L. Lewis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alzheimer's disease peptide -amyloid interacts with fibrinogen and induces its oligomerization
- (2010) H. J. Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 as a Marker of Acute Rejection in Pancreas Allotransplantation in Pigs
- (2010) F.A. García-Gil et al. TRANSPLANTATION PROCEEDINGS
- Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease
- (2009) Alex E. Roher et al. BIOMARKERS
- Genome-wide association studies in Alzheimer's disease
- (2009) L. Bertram et al. HUMAN MOLECULAR GENETICS
- An update on clinical proteomics in Alzheimer’s research
- (2009) Minna A. Korolainen et al. JOURNAL OF NEUROCHEMISTRY
- Elevated Plasma Levels of α -1-Anti-Chymotrypsin in Age-Related Cognitive Decline and Alzheimers Disease: A Potential Therapeutic Target
- (2008) E. Porcellini et al. CURRENT PHARMACEUTICAL DESIGN
- Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma
- (2008) Paul Cutler et al. Proteomics Clinical Applications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now